Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute

Seattle, Washington 98104

0 studies enrolling now · 1 studies all time

What they study most

Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Myelofibrosis

Studies at this site

• Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2) — Running, not enrolling